Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A
Open accessThe DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
Significance: Myostatin and activin A are secreted signaling molecules that act to limit skeletal muscle growth. Here, we show that myostatin and activin A utilize four receptor components to signal directly to muscle fibers. These findings have implications for strategies to target this signaling pathway for clinical applications to treat patients with muscle loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“We and others have previously demonstrated that growth differentiation factor-8 (GDF8; also known as myostatin) and activin A (ActA) are the two major ligands mediating the muscle-minimization actions of ActRIIA/B receptors22,26–30.”
From GDF8 and activin A blockade protects against GLP-1–induced muscle loss while enhancing fat loss in obese male mice and non-human primates (2025) · cites this paper as [29]
In the citing paper
“However, this protection from weight gain with muscle Acvr2a/b deletion is not as great as that seen in Mstn−/− mice, making it plausible that signaling through this pathway could still directly affect adipose tissue [30].”
From Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism (2024) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for assessment of bone microstructure in rodents using micro–computed tomography
Bouxsein, M. L., Boyd, S. K., Christiansen, B. A., Guldberg, R. E., Jepsen, K. J., & Müller, R. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.141 · Cited by 4,433 · cited 1×
“Analysis of femurs and vertebrae was conducted using standard protocols, with a lower threshold of 2,485 Hounsfield units (HU) for femoral trabeculae, 4,932 HU for femoral cortex, and 3,078 HU for vertebral trabeculae (59).”
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Self-citationDouble muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039 · cited 1×
“The sequence of MSTN has been highly conserved through evolution, with the mature MSTN peptide being identical in species as divergent as humans and turkeys (3).”
Self-citationRegulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616 · cited 14×
“One possible candidate was BMPRII, although we were unable to detect significant binding of MSTN to BMPRII in transfected cells (18).”
InfluentialSelf-citationA deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Self-citationClop, A., Marcq, F., Takeda, H., Pirottin, D., Tordoir, X., Bibé, B., Bouix, J., Caiment, F., Elsen, J.-M., Eychenne, F., et al. (2006) · Nature Genetics · doi:10.1038/ng1810 · Cited by 1,260 · cited 1×
“The function of MSTN has also been conserved, and targeted or naturally occurring mutations in MSTN have been shown to cause increased muscling in numerous species, including cattle (3–5), sheep (6), dogs (7), rabbits (8), rats (9), swine (10), goats (11), and humans (12).”
Mutations in myostatin ( GDF8 ) in Double-Muscled Belgian Blue and Piedmontese Cattle
Kambadur, R., Sharma, M., Smith, T. P. L., & Bass, J. J. (1997) · Genome Research · doi:10.1101/gr.7.9.910 · Cited by 1,204
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125 · cited 1×
“Offspring from these matings were then bred with EIIa-Cre transgenic mice (58) in order to delete the neomycin resistance cassette in the germline.”
Activin-Binding Protein from Rat Ovary Is Follistatin
Nakamura, T., Takio, K., Eto, Y., Shibai, H., Titani, K., & Sugino, H. (1990) · Science · doi:10.1126/science.2106159 · Cited by 883 · cited 1×
“For example, the activities of both MSTN and activin A can be modulated extracellularly by naturally occurring inhibitory binding proteins, including follistatin (17, 18) and the follistatin-related protein, FSTL-3 or FLRG (19, 20).”
Mosher, D. S., Quignon, P., Bustamante, C. D., Sutter, N. B., Mellersh, C. S., Parker, H. G., & Ostrander, E. A. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030079 · Cited by 826 · cited 1×
“The function of MSTN has also been conserved, and targeted or naturally occurring mutations in MSTN have been shown to cause increased muscling in numerous species, including cattle (3–5), sheep (6), dogs (7), rabbits (8), rats (9), swine (10), goats (11), and humans (12).”
Rebbapragada, A., Benchabane, H., Wrana, J. L., Celeste, A. J., & Attisano, L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7230-7242.2003 · Cited by 565 · cited 6×
“Based on in vitro studies, MSTN is capable of binding initially to the activin type II receptors, ACVR2 and ACVR2B (also called ActRIIA and ActRIIB) (18) followed by engagement of the type I receptors, ALK4 and ALK5 (21).”
InfluentialAbnormal angiogenesis but intact hematopoietic potential in TGF‐β type I receptor‐deficient mice
Larsson, J., Goumans, M., Sjöstrand, L. J., van Rooijen, M. A., Ward, D., Levéen, P., Xu, X., ten Dijke, P., Mummery, C. L., & Karlsson, S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1663 · Cited by 563 · cited 16×
“1 D and Table 1, targeting both Acvr2b and Alk5 resulted generally in greater increases in muscle mass than targeting either alone, implying that the ACVR2/ALK4 combination cannot be the sole one that is used in vivo; however, the increases seen in these mice did not approach those seen either in mice lacking both typ…”
InfluentialSuppression of body fat accumulation in myostatin-deficient mice
McPherron, A. C., & Lee, S.-J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213562 · Cited by 505
Self-citationRegulation of muscle growth by multiple ligands signaling through activin type II receptors
Lee, S.-J., Reed, L. A., Davies, M. V., Girgenrath, S., Goad, M. E. P., Tomkinson, K. N., Wright, J. F., Barker, C., Ehrmantraut, G., Holmstrom, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505996102 · Cited by 501 · cited 9×
“One approach was to generate a soluble form of ACVR2B in which the ligand-binding domain was fused to an immunoglobulin Fc domain (13, 41).”
InfluentialSelf-citationBMP signaling controls muscle mass
Sartori, R., Schirwis, E., Blaauw, B., Bortolanza, S., Zhao, J., Enzo, E., Stantzou, A., Mouisel, E., Toniolo, L., Ferry, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2772 · Cited by 467 · cited 1×
“Moreover, a previous study suggested that BMP signaling may actually have the opposite effect of inducing muscle growth (27); specifically, this study reported that expression of a constitutively active type I BMP receptor (ALK3) can induce muscle growth and, conversely, that overexpression of the BMP inhibitor, noggi…”
Hill, J. J., Davies, M. V., Pearson, A. A., Wang, J. H., Hewick, R. M., Wolfman, N. M., & Qiu, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206379200 · Cited by 443 · cited 2×
“For example, the activities of both MSTN and activin A can be modulated extracellularly by naturally occurring inhibitory binding proteins, including follistatin (17, 18) and the follistatin-related protein, FSTL-3 or FLRG (19, 20).”
Guo, T., Jou, W., Chanturiya, T., Portas, J., Gavrilova, O., & McPherron, A. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004937 · Cited by 402 · cited 1×
“In this regard, a previous study showed that mice overexpressing a truncated form of ACVR2B in skeletal muscle (18) also exhibit some of the metabolic effects seen in Mstn mice (51); however, because this truncated receptor could act as a ligand trap, one could not rule out the possibility that one mode of action of t…”
Quadrupling Muscle Mass in Mice by Targeting TGF-ß Signaling Pathways
Lee, S.-J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000789 · Cited by 316
Self-citationLach-Trifilieff, E., Minetti, G. C., Sheppard, K., Ibebunjo, C., Feige, J. N., Hartmann, S., Brachat, S., Rivet, H., Koelbing, C., Morvan, F., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01307-13 · Cited by 306 · cited 1×
“A second approach, which was taken by Novartis, was to develop a monoclonal antibody targeting ACVR2B directly (42 – 46).”
Regulation of Muscle Mass by Follistatin and Activins
Lee, S.-J., Lee, Y.-S., Zimmers, T. A., Soleimani, A., Matzuk, M. M., Tsuchida, K., Cohn, R. D., & Barton, E. R. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0127 · Cited by 273 · cited 3×
“In previous studies, we showed that the function of MSTN in limiting muscle growth is redundant with that of at least one other TGF-β family member (13, 14), and several studies have implicated activin A as at least one of the key cooperating ligands (15, 16).”
Self-citationRooks, D., Praestgaard, J., Hariry, S., Laurent, D., Petricoul, O., Perry, R. G., Lach‐Trifilieff, E., & Roubenoff, R. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14927 · Cited by 244
Campbell, C., McMillan, H. J., Mah, J. K., Tarnopolsky, M., Selby, K., McClure, T., Wilson, D. M., Sherman, M. L., Escolar, D., & Attie, K. M. (2017) · Muscle & Nerve · doi:10.1002/mus.25268 · Cited by 240 · cited 1×
“One approach was to generate a soluble form of ACVR2B in which the ligand-binding domain was fused to an immunoglobulin Fc domain (13, 41).”
Treatment of sporadic inclusion body myositis with bimagrumab
Amato, A. A., Sivakumar, K., Goyal, N., David, W. S., Salajegheh, M., Praestgaard, J., Lach-Trifilieff, E., Trendelenburg, A.-U., Laurent, D., Glass, D. J., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001070 · Cited by 210
Song, J., Oh, S. P., Schrewe, H., Nomura, M., Lei, H., Okano, M., Gridley, T., & Li, E. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9370 · Cited by 193 · cited 2×
“One limitation of that study was that examining the consequence of complete loss of both receptors was not possible using the deletion alleles for these genes because mice completely lacking both receptors are not viable (22).”
Tsuchida, K., Arai, K. Y., Kuramoto, Y., Yamakawa, N., Hasegawa, Y., & Sugino, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006114200 · Cited by 192 · cited 2×
“For example, the activities of both MSTN and activin A can be modulated extracellularly by naturally occurring inhibitory binding proteins, including follistatin (17, 18) and the follistatin-related protein, FSTL-3 or FLRG (19, 20).”
Activin A more prominently regulates muscle mass in primates than does GDF8
Latres, E., Mastaitis, J., Fury, W., Miloscio, L., Trejos, J., Pangilinan, J., Okamoto, H., Cavino, K., Na, E., Papatheodorou, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms15153 · Cited by 185 · cited 3×
“In previous studies, we showed that the function of MSTN in limiting muscle growth is redundant with that of at least one other TGF-β family member (13, 14), and several studies have implicated activin A as at least one of the key cooperating ligands (15, 16).”
Camporez, J.-P. G., Petersen, M. C., Abudukadier, A., Moreira, G. V., Jurczak, M. J., Friedman, G., Haqq, C. M., Petersen, K. F., & Shulman, G. I. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525795113 · Cited by 184
Allen, D. L., Cleary, A. S., Speaker, K. J., Lindsay, S. F., Uyenishi, J., Reed, J. M., Madden, M. C., & Mehan, R. S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00798.2007 · Cited by 183 · cited 1×
“Moreover, although Mstn is expressed at low levels in adipose tissue in wild-type mice (2), Mstn expression is significantly up-regulated in both subcutaneous and visceral fat in ob/ob mice (53).”
LeBrasseur, N. K., Schelhorn, T. M., Bernardo, B. L., Cosgrove, P. G., Loria, P. M., & Brown, T. A. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glp068 · Cited by 180
Lee, S.-J., Huynh, T. V., Lee, Y.-S., Sebald, S. M., Wilcox-Adelman, S. A., Iwamori, N., Lepper, C., Matzuk, M. M., & Fan, C.-M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206410109 · Cited by 167 · cited 6×
“Mice carrying floxed alleles for Acvr2 (24), Acvr2b (23), Alk5 (26), Bmpr2 (28), Cfc1b (57), and Mstn (32) have been described previously.”
InfluentialSelf-citationRedundancy of myostatin and growth/differentiation factor 11 function
McPherron, A. C., Huynh, T. V., & Lee, S.-J. (2009) · BMC Developmental Biology · doi:10.1186/1471-213x-9-24 · Cited by 165 · cited 2×
“In the studies presented here, we targeted these receptors by crossing in a myosin light chain-cre (Myl1-cre) transgene (25), which is expressed specifically by myofibers, into mice that we had generated carrying floxed alleles for Acvr2 and Acvr2b.”
Self-citationEfficient Generation of Myostatin Gene Mutated Rabbit by CRISPR/Cas9
Lv, Q., Yuan, L., Deng, J., Chen, M., Wang, Y., Zeng, J., Li, Z., & Lai, L. (2016) · Scientific Reports · doi:10.1038/srep25029 · Cited by 145 · cited 1×
“The function of MSTN has also been conserved, and targeted or naturally occurring mutations in MSTN have been shown to cause increased muscling in numerous species, including cattle (3–5), sheep (6), dogs (7), rabbits (8), rats (9), swine (10), goats (11), and humans (12).”
Morvan, F., Rondeau, J.-M., Zou, C., Minetti, G., Scheufler, C., Scharenberg, M., Jacobi, C., Brebbia, P., Ritter, V., Toussaint, G., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707925114 · Cited by 142 · cited 1×
“Although the initial publication of this monoclonal antibody (bimagrumab, or BYM338) reported that it had over 200-fold higher affinity for ACVR2B compared to ACVR2, subsequent studies showed that by X-ray crystallography analysis, BYM338 is capable of blocking the ligand-binding domain of both receptors (47).”
The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity
Akpan, I., Goncalves, M. D., Dhir, R., Yin, X., Pistilli, E. E., Bogdanovich, S., Khurana, T. S., Ucran, J., Lachey, J., & Ahima, R. S. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.162 · Cited by 140
Inhibition of Preadipocyte Differentiation by Myostatin Treatment in 3T3-L1 Cultures
Kim, H., Liang, L., Dean, R. G., Hausman, D. B., Hartzell, D. L., & Baile, C. A. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4435 · Cited by 127 · cited 1×
“Indeed, among the cell types known to be responsive to MSTN in cell culture are adipocytes (52).”
Muscular atrophy of caveolin-3–deficient mice is rescued by myostatin inhibition
Ohsawa, Y., Hagiwara, H., Nakatani, M., Yasue, A., Moriyama, K., Murakami, T., Tsuchida, K., Noji, S., & Sunada, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28520 · Cited by 120 · cited 1×
“In particular, whereas small-molecule inhibitors of ALK4/5 were shown to induce muscle fiber hypertrophy in both wild-type and dystrophic mice (48) as well as to preserve muscle mass in a cancer cachexia model (49), delivery of an antisense oligonucleotide directed against Alk4 had the opposite effect, leading to a re…”
CRISPR/Cas9-mediated knockout of myostatin in Chinese indigenous Erhualian pigs
Wang, K., Tang, X., Xie, Z., Zou, X., Li, M., Yuan, H., Guo, N., Ouyang, H., Jiao, H., & Pang, D. (2017) · Transgenic Research · doi:10.1007/s11248-017-0044-z · Cited by 100 · cited 1×
“The function of MSTN has also been conserved, and targeted or naturally occurring mutations in MSTN have been shown to cause increased muscling in numerous species, including cattle (3–5), sheep (6), dogs (7), rabbits (8), rats (9), swine (10), goats (11), and humans (12).”
Effect of bimagrumab on thigh muscle volume and composition in men with casting‐induced atrophy
Rooks, D. S., Laurent, D., Praestgaard, J., Rasmussen, S., Bartlett, M., & Tankó, L. B. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12205 · Cited by 90
Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals
Garito, T., Roubenoff, R., Hompesch, M., Morrow, L., Gomez, K., Rooks, D., Meyers, C., Buchsbaum, M. S., Neelakantham, S., Swan, T., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13042 · Cited by 88 · cited 1×
“A second approach, which was taken by Novartis, was to develop a monoclonal antibody targeting ACVR2B directly (42 – 46).”
Bone Mineral Content and Density in the Humerus of Adult Myostatin-Deficient Mice
Hamrick, M. W., McPherron, A. C., & Lovejoy, C. O. (2002) · Calcified Tissue International · doi:10.1007/s00223-001-1109-8 · Cited by 85 · cited 2×
“Prior studies have identified effects on bone density and structure in Mstn − / − mice (38).”
He, Z., Zhang, T., Jiang, L., Zhou, M., Wu, D., Mei, J., & Cheng, Y. (2018) · Bioscience Reports · doi:10.1042/bsr20180742 · Cited by 79 · cited 1×
“The function of MSTN has also been conserved, and targeted or naturally occurring mutations in MSTN have been shown to cause increased muscling in numerous species, including cattle (3–5), sheep (6), dogs (7), rabbits (8), rats (9), swine (10), goats (11), and humans (12).”
Effects of the activin A–myostatin–follistatin system on aging bone and muscle progenitor cells
Bowser, M., Herberg, S., Arounleut, P., Shi, X., Fulzele, S., Hill, W. D., Isales, C. M., & Hamrick, M. W. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2012.11.004 · Cited by 75 · cited 1×
“In this regard, MSTN has been reported to be capable of acting directly on bone-progenitor cells in vitro to regulate cell differentiation (54).”
Cell‐type specific regulation of myostatin signaling
Kemaladewi, D. U., de Gorter, D. J. J., Aartsma-Rus, A. M., van Ommen, G. B., ten Dijke, P., Hoen, P. A. C. ’., & Hoogaars, W. M. H. (2011) · The FASEB Journal · doi:10.1096/fj.11-191189 · Cited by 72 · cited 2×
“In this regard, one study using C2C12 myoblasts reported that cripto is required for MSTN signaling but inhibits activin A signaling (30); another study, however, showed that during muscle regeneration in vivo, cripto expressed by satellite cells acts to antagonize MSTN signaling (31).”
Koncarevic, A., Cornwall-Brady, M., Pullen, A., Davies, M., Sako, D., Liu, J., Kumar, R., Tomkinson, K., Baker, T., Umiker, B., et al. (2010) · Endocrinology · doi:10.1210/en.2010-0134 · Cited by 71 · cited 1×
“In addition, we (13, 24, 39) and others (35, 40) have reported that administration of a soluble form of the activin type IIB receptor (ACVR2B/Fc) systemically to mice can increase not only muscle mass but also bone mineral density.”
Increased Muscle Force Production and Bone Mineral Density in ActRIIB-Fc-Treated Mature Rodents
Chiu, C.-S., Peekhaus, N., Weber, H., Adamski, S., Murray, E. M., Zhang, H. Z., Zhao, J. Z., Ernst, R., Lineberger, J., Huang, L., et al. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt030 · Cited by 68 · cited 2×
“It is also known that MSTN inhibitors, like follistatin and the ACVR2B/Fc decoy receptor, can have significant effects on bone repair and bone density in vivo (39, 40, 55, 56), but because these inhibitors can also block activin signaling, the identities of the key ligands being blocked in these studies is not clear.”
ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass
Barreto, R., Kitase, Y., Matsumoto, T., Pin, F., Colston, K. C., Couch, K. E., O’Connell, T. M., Couch, M. E., Bonewald, L. F., & Bonetto, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-15040-1 · Cited by 68 · cited 1×
“…MSTN inhibitors, like follistatin and the ACVR2B/Fc decoy receptor, can have significant effects on bone repair and bone density in vivo (39, 40, 55, 56), but because these inhibitors can also block activin signaling, the identities of the key ligands being blocked in these studies is not clear.”
Non-cell-autonomous role for Cripto in axial midline formation during vertebrate embryogenesis
Chu, J., Ding, J., Jeays-Ward, K., Price, S. M., Placzek, M., & Shen, M. M. (2005) · Development · doi:10.1242/dev.02157 · Cited by 63 · cited 7×
“We did, however, see an effect of targeting Cfc1b in combination with Acvr2 , which resulted in small, but significant, increases in muscle mass compared to targeting Acvr2 alone.”
InfluentialSelf-citationGoh, B. C., Singhal, V., Herrera, A. J., Tomlinson, R. E., Kim, S., Faugere, M.-C., Germain-Lee, E. L., Clemens, T. L., Lee, S.-J., & DiGirolamo, D. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.782128 · Cited by 63 · cited 5×
“Similarly, it is known that targeting activin type II receptors in osteoblasts in vivo can also increase bone density (24), but this effect likely reflects inhibition of signaling by activin rather than by MSTN.”
InfluentialSelf-citationDiGirolamo, D. J., Singhal, V., Chang, X., Lee, S.-J., & Germain-Lee, E. L. (2015) · Bone Research · doi:10.1038/boneres.2014.42 · Cited by 56 · cited 3×
“It is also known that MSTN inhibitors, like follistatin and the ACVR2B/Fc decoy receptor, can have significant effects on bone repair and bone density in vivo (39, 40, 55, 56), but because these inhibitors can also block activin signaling, the identities of the key ligands being blocked in these studies is not clear.”
Self-citationAn evolving web of signaling networks regulated by Cripto-1
Nagaoka, T., Karasawa, H., Castro, N. P., Rangel, M. C., Salomon, D. S., & Bianco, C. (2012) · Growth Factors · doi:10.3109/08977194.2011.641962 · Cited by 55 · cited 1×
“29).”
Inhibition of GDF8 (Myostatin) accelerates bone regeneration in diabetes mellitus type 2
Wallner, C., Jaurich, H., Wagner, J. M., Becerikli, M., Harati, K., Dadras, M., Lehnhardt, M., & Behr, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-10404-z · Cited by 51 · cited 1×
“It is also known that MSTN inhibitors, like follistatin and the ACVR2B/Fc decoy receptor, can have significant effects on bone repair and bone density in vivo (39, 40, 55, 56), but because these inhibitors can also block activin signaling, the identities of the key ligands being blocked in these studies is not clear.”
Guardiola, O., Lafuste, P., Brunelli, S., Iaconis, S., Touvier, T., Mourikis, P., De Bock, K., Lonardo, E., Andolfi, G., Bouché, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204017109 · Cited by 50 · cited 1×
“In this regard, one study using C2C12 myoblasts reported that cripto is required for MSTN signaling but inhibits activin A signaling (30); another study, however, showed that during muscle regeneration in vivo, cripto expressed by satellite cells acts to antagonize MSTN signaling (31).”
Self-citationGeneration of a floxed allele of the mouse BMP type II receptor gene
Beppu, H., Lei, H., Bloch, K. D., & Li, E. (2005) · genesis · doi:10.1002/gene.20099 · Cited by 47 · cited 4×
“Mice carrying floxed alleles for Acvr2 (24), Acvr2b (23), Alk5 (26), Bmpr2 (28), Cfc1b (57), and Mstn (32) have been described previously.”
InfluentialEstablishment and phenotypic analysis of an Mstn knockout rat
Gu, H., Cao, Y., Qiu, B., Zhou, Z., Deng, R., Chen, Z., Li, R., Li, X., Wei, Q., Xia, X., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.030 · Cited by 39 · cited 1×
“The function of MSTN has also been conserved, and targeted or naturally occurring mutations in MSTN have been shown to cause increased muscling in numerous species, including cattle (3–5), sheep (6), dogs (7), rabbits (8), rats (9), swine (10), goats (11), and humans (12).”
Paracrine and endocrine modes of myostatin action
Lee, Y.-S., Huynh, T. V., & Lee, S.-J. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00874.2015 · Cited by 37 · cited 2×
“Mice carrying floxed alleles for Acvr2 (24), Acvr2b (23), Alk5 (26), Bmpr2 (28), Cfc1b (57), and Mstn (32) have been described previously.”
Self-citationPasteuning-Vuhman, S., der Meulen, J. W. B.-V., van Putten, M., Overzier, M., ten Dijke, P., Kiełbasa, S. M., Arindrarto, W., Wolterbeek, R., Lezhnina, K. V., Ozerov, I. V., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201600675r · Cited by 32 · cited 1×
“In particular, whereas small-molecule inhibitors of ALK4/5 were shown to induce muscle fiber hypertrophy in both wild-type and dystrophic mice (48) as well as to preserve muscle mass in a cancer cachexia model (49), delivery of an antisense oligonucleotide directed against Alk4 had the opposite effect, leading to a re…”
Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting
Levolger, S., Wiemer, E. A. C., van Vugt, J. L. A., Huisman, S. A., van Vledder, M. G., den Engel, S. V. D.-V., Ambagtsheer, G., IJzermans, J. N. M., & de Bruin, R. W. F. (2019) · Scientific Reports · doi:10.1038/s41598-019-46178-9 · Cited by 20 · cited 1×
“In particular, whereas small-molecule inhibitors of ALK4/5 were shown to induce muscle fiber hypertrophy in both wild-type and dystrophic mice (48) as well as to preserve muscle mass in a cancer cachexia model (49), delivery of an antisense oligonucleotide directed against Alk4 had the opposite effect, leading to a re…”
Lee, S.-J. (2012) · Muscle · doi:10.1016/b978-0-12-381510-1.00079-x · Cited by 8
Self-citation
Cited by
Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction
Lee, S.-J. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148372 · Cited by 143
“Studies in mice have demonstrated clearly that blocking signaling by ACVR2 and ACVR2B just in skeletal myofibers not only can induce significant muscle growth but also can reduce total body fat content and improve glucose metabolism (34).”
InfluentialSelf-citationNunn, E., Jaiswal, N., Gavin, M., Uehara, K., Stefkovich, M., Drareni, K., Calhoun, R., Lee, M., Holman, C. D., Baur, J. A., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101880 · Cited by 126
Myostatin: a skeletal muscle chalone
Lee, S.-J. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012422-112116 · Cited by 84
Self-citationAbati, E., Manini, A., Comi, G. P., & Corti, S. P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04408-w · Cited by 89
“Indeed, the two type I receptors, ALK4 and ALK5, seem to have a much greater expression in muscle mass than the two type II receptors, at least in rodent models [75].”
BackgroundSolagna, F., Tezze, C., Lindenmeyer, M. T., Lu, S. Y., Wu, G., Liu, S., Zhao, Y., Mitchell, R., Meyer, C., Omairi, S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci135821 · Cited by 68
“Indeed, a recent study (69) showed how targeting the Acvr2b and Acvr2a in muscle leads to muscle hypertrophy.”
Background
Metadata
- Authors
- Lee, S.-J., Lehar, A., Liu, Y., Ly, C. H., Pham, Q.-M., Michaud, M., Rydzik, R., Youngstrom, D. W., Shen, M. M., Kaartinen, V., Germain-Lee, E. L., & Rando, T. A.
- Affiliations
- University of Connecticut (US)
- The Jackson Laboratory for Genomic Medicine (US)
- Stanford Medicine (US)
- Columbia University (US)
- University of Michigan (US)
- Department of Pediatrics, University of Connecticut School of Medicine, Farmington, CT 06030;
- VA Palo Alto Health Care System (US)
- Corresponding author
- Lee, Se-Jin
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2020-11-20
- Volume
- 117
- Issue
- 49
- Pages
- 30907-30917
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC7733802
- OpenAlex
- W3106391536
- Semantic Scholar
- c1e334b7787a8b6449f81488ecbf0e86104490e7
- Cited by
- 59
- References
- 60
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 10 · 2023: 10 · 2022: 12 · 2021: 6 · 2020: 1
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion, cc-by-nc-nd)
- Funders
- HHS | National Institutes of Health (R01AR060636, R01AG052962)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- myostatin, activin A, skeletal muscle growth, TGF-beta signaling, ACVR2, ACVR2B, ALK4, ALK5, muscle mass, fat mass, glucose metabolism, high-fat diet, satellite cells, muscle regeneration, bone mineral density
- MeSH terms
- Animals, Mice, Inbred C57BL, Muscles, Organ Size, Muscle Fibers, Skeletal, Muscle Development, Activins, Activin Receptors, Type I, Activin Receptors, Type II, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.